The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Factrel     N-[1-[[1-[[1-[[1-[[1-[[1-[2...

Synonyms: Kryptocur, LHFSHRH, Luliberin, Cystorelin, Dirigestran, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Dirigestran


Psychiatry related information on Dirigestran


High impact information on Dirigestran


Chemical compound and disease context of Dirigestran


Biological context of Dirigestran


Anatomical context of Dirigestran


Associations of Dirigestran with other chemical compounds


Gene context of Dirigestran


Analytical, diagnostic and therapeutic context of Dirigestran


  1. Pamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer. Smith, M.R., McGovern, F.J., Zietman, A.L., Fallon, M.A., Hayden, D.L., Schoenfeld, D.A., Kantoff, P.W., Finkelstein, J.S. N. Engl. J. Med. (2001) [Pubmed]
  2. Adult-onset idiopathic hypogonadotropic hypogonadism--a treatable form of male infertility. Nachtigall, L.B., Boepple, P.A., Pralong, F.P., Crowley, W.F. N. Engl. J. Med. (1997) [Pubmed]
  3. Familial precocious puberty associated with isolated elevation of luteinizing hormone. Rosenfeld, R.G., Reitz, R.E., King, A.B., Hintz, R.L. N. Engl. J. Med. (1980) [Pubmed]
  4. Parathyroid hormone for the prevention of bone loss induced by estrogen deficiency. Finkelstein, J.S., Klibanski, A., Schaefer, E.H., Hornstein, M.D., Schiff, I., Neer, R.M. N. Engl. J. Med. (1994) [Pubmed]
  5. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Matthews, C.H., Borgato, S., Beck-Peccoz, P., Adams, M., Tone, Y., Gambino, G., Casagrande, S., Tedeschini, G., Benedetti, A., Chatterjee, V.K. Nat. Genet. (1993) [Pubmed]
  6. Treatment of paraphilia with an analogue of gonadotropin-releasing hormone. Reichlin, S. N. Engl. J. Med. (1998) [Pubmed]
  7. The premenstrual syndrome. Effects of "medical ovariectomy". Muse, K.N., Cetel, N.S., Futterman, L.A., Yen, S.C. N. Engl. J. Med. (1984) [Pubmed]
  8. Brain immunoreactive gonadotropin-releasing hormone in Huntington's chorea and in non-choreic subjects. Bird, E.D., Chiappa, S.A., Fink, G. Nature (1976) [Pubmed]
  9. Multiple circadian oscillators regulate the timing of behavioral and endocrine rhythms in female golden hamsters. Swann, J.M., Turek, F.W. Science (1985) [Pubmed]
  10. Stress-induced inhibition of reproductive functions: role of endogenous corticotropin-releasing factor. Rivier, C., Rivier, J., Vale, W. Science (1986) [Pubmed]
  11. Neuroendocrine-immune system interactions and autoimmunity. Wilder, R.L. Annu. Rev. Immunol. (1995) [Pubmed]
  12. Olfactory inputs to hypothalamic neurons controlling reproduction and fertility. Yoon, H., Enquist, L.W., Dulac, C. Cell (2005) [Pubmed]
  13. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Wu, W., Cogan, J.D., Pfäffle, R.W., Dasen, J.S., Frisch, H., O'Connell, S.M., Flynn, S.E., Brown, M.R., Mullis, P.E., Parks, J.S., Phillips, J.A., Rosenfeld, M.G. Nat. Genet. (1998) [Pubmed]
  14. Treatment of men with paraphilia with a long-acting analogue of gonadotropin-releasing hormone. Rösler, A., Witztum, E. N. Engl. J. Med. (1998) [Pubmed]
  15. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. Schmidt, P.J., Nieman, L.K., Danaceau, M.A., Adams, L.F., Rubinow, D.R. N. Engl. J. Med. (1998) [Pubmed]
  16. Recognition of gonadotroph adenomas in women. Daneshdoost, L., Gennarelli, T.A., Bashey, H.M., Savino, P.J., Sergott, R.C., Bosley, T.M., Snyder, P.J. N. Engl. J. Med. (1991) [Pubmed]
  17. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. Schmidt, P.J., Nieman, L.K., Grover, G.N., Muller, K.L., Merriam, G.R., Rubinow, D.R. N. Engl. J. Med. (1991) [Pubmed]
  18. Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. Holland, F.J., Fishman, L., Bailey, J.D., Fazekas, A.T. N. Engl. J. Med. (1985) [Pubmed]
  19. Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone. Rajfer, J., Handelsman, D.J., Swerdloff, R.S., Hurwitz, R., Kaplan, H., Vandergast, T., Ehrlich, R.M. N. Engl. J. Med. (1986) [Pubmed]
  20. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Shenker, A., Laue, L., Kosugi, S., Merendino, J.J., Minegishi, T., Cutler, G.B. Nature (1993) [Pubmed]
  21. Induction of ovulation and fertility in amenorrheic women by pulsatile low-dose gonadotropin-releasing hormone. Hurley, D.M., Brian, R., Outch, K., Stockdale, J., Fry, A., Hackman, C., Clarke, I., Burger, H.G. N. Engl. J. Med. (1984) [Pubmed]
  22. Incidence of early loss of pregnancy. Wilcox, A.J., Weinberg, C.R., O'Connor, J.F., Baird, D.D., Schlatterer, J.P., Canfield, R.E., Armstrong, E.G., Nisula, B.C. N. Engl. J. Med. (1988) [Pubmed]
  23. Reversible inhibition of testicular steroidogenesis and spermatogenesis by a potent gonadotropin-releasing hormone agonist in normal men: an approach toward the development of a male contraceptive. Linde, R., Doelle, G.C., Alexander, N., Kirchner, F., Vale, W., Rivier, J., Rabin, D. N. Engl. J. Med. (1981) [Pubmed]
  24. Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. Weiss, J., Axelrod, L., Whitcomb, R.W., Harris, P.E., Crowley, W.F., Jameson, J.L. N. Engl. J. Med. (1992) [Pubmed]
  25. Hormonal regulation of ovarian cellular proliferation. Rao, M.C., Midgley, A.R., Richards, J.S. Cell (1978) [Pubmed]
  26. A controlled study of luteinizing hormone-releasing hormone agonist (buserelin) for the induction of folliculogenesis before in vitro fertilization. MacLachlan, V., Besanko, M., O'Shea, F., Wade, H., Wood, C., Trounson, A., Healy, D.L. N. Engl. J. Med. (1989) [Pubmed]
  27. Presence in normal human testes of a chorionic-gonadotropin-like substance distinct from human luteinizing hormone. Braunstein, G.D., Rasor, J., Wade, M.E. N. Engl. J. Med. (1975) [Pubmed]
  28. A chronobiologic abnormality in luteinizing hormone secretion in teenage girls with the polycystic-ovary syndrome. Zumoff, B., Freeman, R., Coupey, S., Saenger, P., Markowitz, M., Kream, J. N. Engl. J. Med. (1983) [Pubmed]
  29. Detection of functional ovarian hyperandrogenism in women with androgen excess. Ehrmann, D.A., Rosenfield, R.L., Barnes, R.B., Brigell, D.F., Sheikh, Z. N. Engl. J. Med. (1992) [Pubmed]
  30. Dopamine stimulates the degradation of gonadotropin releasing hormone by rat synaptosomes. Marcano de Cotte, D., De Menezes, C.E., Bennett, G.W., Edwardson, J.A. Nature (1980) [Pubmed]
  31. The nuclear receptor co-repressor nrip1 (RIP140) is essential for female fertility. White, R., Leonardsson, G., Rosewell, I., Ann Jacobs, M., Milligan, S., Parker, M. Nat. Med. (2000) [Pubmed]
  32. Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Lee, S.L., Sadovsky, Y., Swirnoff, A.H., Polish, J.A., Goda, P., Gavrilina, G., Milbrandt, J. Science (1996) [Pubmed]
  33. New roles for estrogen receptor beta in behavior and neuroendocrinology. Bodo, C., Rissman, E.F. Frontiers in neuroendocrinology. (2006) [Pubmed]
  34. The ontogenesis of human fetal hormones. III. Prolactin. Aubert, M.J., Grumbach, M.M., Kaplan, S.L. J. Clin. Invest. (1975) [Pubmed]
  35. Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer. Spitz, I.M., Chertin, B., Lindenberg, T., Farkas, A. N. Engl. J. Med. (1999) [Pubmed]
  36. Restoration of normal pituitary gonadotropin reserve by administration of luteinizing-hormone-releasing hormone in patients with hypogonadotropic hypogonadism. Yoshimoto, Y., Moridera, K., Imura, H. N. Engl. J. Med. (1975) [Pubmed]
  37. Hypothalamic hamartoma: a source of luteinizing-hormone-releasing factor in precocious puberty. Judge, D.M., Kulin, H.E., Page, R., Santen, R., Trapukdi, S. N. Engl. J. Med. (1977) [Pubmed]
  38. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone. Hoffman, A.R., Crowley, W.F. N. Engl. J. Med. (1982) [Pubmed]
WikiGenes - Universities